The Wall Street Journal Western Edition 1998 Rochelle Sharpe - Abstracts

The Wall Street Journal Western Edition 1998 Rochelle Sharpe
TitleSubjectAuthors
An obscure rule helps food bar's pitch.('medical food' falls under the FDA's Orphan Drug Act of 1988)(Abstract)Business, generalRochelle Sharpe
FDA expected to approve new drug from CollaGenex to fight gum disease.Business, generalRochelle Sharpe
FDA gets a cautious recommendation to approve vaccine for Lyme disease.Business, generalOtesa Middleton, Rochelle Sharpe
FDA panel backs Searle arthritis drug but suggests warnings about side effects.(Abstract)Business, generalRochelle Sharpe
FDA received data on adverse effects from using Viagra.Business, generalRochelle Sharpe
FDA rules dietary supplement dupes cholesterol drug, raising legal issues.Business, generalRochelle Sharpe
Healthy women can use cancer drug.(Zeneca Group PLC's Nolvadex)(Abstract)Business, generalRochelle Sharpe
Johnson & Johnson could face delay in bringing Benecol products to market.(cholesterol-reducing products' marketing fate might be in the hands of the FDA)(Abstract)Business, generalRochelle Sharpe
Look-alike names lead to drug mix-ups.(Abstract)Business, generalRochelle Sharpe
Medicine for flare-ups of cancer pain, Anesta's Actiq, is approved by the FDA.(Actiq is a pain management lozenge made by Anesta Corp.)(Abstract)Business, generalRochelle Sharpe
Parkinson's drug will carry strict safety warning.(Hoffmann-LaRoche's drug for Parkinson's disease, Tasmar)(Abstract)Business, generalRochelle Sharpe
Researchers say Hoechst drug may be treatment for cocaine, nicotine addicts.Business, generalRochelle Sharpe
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.